Author:
Bares Sara H.,Scarsi Kimberly K.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Virology,Infectious Diseases,Oncology (nursing),Oncology,Hematology,Immunology
Reference31 articles.
1. The promise of improved adherence with long-acting antiretroviral therapy: what are the data?;Scarsi;J Int Assoc Provid AIDS Care,2021
2. Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception;Delany-Moretlwe;Curr Opin HIV AIDS,2016
3. Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial;Margolis;Lancet Infect Dis,2015
4. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, noninferiority trial;Margolis;Lancet,2017
5. Long-acting injectable therapy: an emerging paradigm for the treatment of HIV infection;D’Amico;Curr Opin HIV AIDS,2020
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献